Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737

Immunotoxins are antibody–toxin fusion proteins directed to kill cancer cells displaying specific target antigens on their surface. Remarkably, immunotoxins directed to CD22 on hairy cell leukemia have produced complete remissions in approximately 60% of patients enrolled in phase I/II trials. For r...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Leuk Lymphoma
Päätekijät: FITZGERALD, DAVID J., MOSKATEL, ELIZABETH, BEN-JOSEF, GAL, TRAINI, ROBERTA, TENDLER, TARA, SHARMA, ASHIMA, ANTIGNANI, ANTONELLA, MUSSAI, FRANCIS, WAYNE, ALAN, KREITMAN, ROBERT J., PASTAN, IRA
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7450489/
https://ncbi.nlm.nih.gov/pubmed/21599608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2011.569961
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia